LANDEC CORPORATION (NASDAQ:LNDC) Files An 8-K Results of Operations and Financial Condition
Item 2.02
|
Results of Operations and Financial |
On April 4, 2017, Landec Corporation (the Registrant) issued a
press release announcing its consolidated financial results for
the thirdquarter of fiscal year 2017 ended February 26, 2017. The
press release is furnished herewith as Exhibit 99.1.
The information in this Current Report including Exhibit 99.1 is
being furnished and shall not be deemed filed for purposes of
Section 18 of the Securities Exchange Act of 1934, as amended
(the Exchange Act) or otherwise subject to the liabilities of
that Section. The information in this Current Report including
Exhibit 99.1 shall not be incorporated by reference in any filing
under the Securities Act of 1933, as amended or the Exchange Act,
except as shall be expressly set forth by specific reference in
such a filing.
Item 9.01. Financial Statements and
Exhibits.
(d)Exhibit.
The following exhibits are furnished as part of this report:
|
Exhibit No. |
Description |
|
99.1 |
Registrants Press Release dated April 4, 2017 regarding |
About LANDEC CORPORATION (NASDAQ:LNDC)
Landec Corporation designs, develops, manufactures and sells a range of health and wellness products for food and biomaterials markets. The Company licenses technology applications to partners. The Company operates through three segments: Packaged Fresh Vegetables, Food Export and Biomaterials. The Packaged Fresh Vegetables segment markets and packs specialty packaged whole and fresh-cut fruit and vegetables, the majority of which incorporate the BreatheWay specialty packaging for the retail grocery, club store and food services industry. The Food Export segment is engaged in the purchase and sale of whole commodity fruit and vegetable products primarily to Asia. The Biomaterials segment sells products utilizing hyaluronan, a polysaccharide that is distributed in the extracellular matrix of connective tissues in both animals and humans, and non-hyaluronan (HA) products for medical use primarily in the ophthalmic, orthopedic and other markets. LANDEC CORPORATION (NASDAQ:LNDC) Recent Trading Information
LANDEC CORPORATION (NASDAQ:LNDC) closed its last trading session up +0.75 at 14.25 with 155,641 shares trading hands.
